Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

Memorial Sloan Kettering Cancer Center, New York

Penn State Milton S. Hershey Medical Center, Hershey

Hospital Of The University Of Pennsylvania, Philadelphia

University Of Virginia Health System, Charlottesville

Fundacion Jimenez Diaz, Madrid

Local Institution, Pamplona

Local Institution, Pessac

Local Institution, Rennes

Local Institution, Essen

Indiana University Cancer Center, Indianapolis

Karmanos Cancer Institute, Detroit

Local Institution, Lille

University Of Chicago, Chicago

Local Institution, Pierre-Bénite

Local Institution, Paris

Division Of Hematology & Oncology Ctr. For Health Sciences, Los Angeles

Local Institution, Créteil

Stanford University Medical Center, Stanford

Local Institution, Villejuif

Providence Portland Med Ctr, Portland

Dana Farber Cancer Institute, Boston

John Theurer Cancer Center, Hackensack

Local Institution, Rouen

Hospital Universitari Vall D'Hebron, Barcelona